Unlike treatments specifically designed to reduce body fat, BPC-157 does not appear to directly influence the biological pathways responsible for fat burning
This convergence of function prompted the investigation into AngIV analogs as potential modulators of the HGF/c-Met pathway
It seems a subset of individuals who dont need or want to lose that much weight have turned to microdosing, which involves taking lower or less frequent doses of these drugs to lose smaller amounts of weightan approach unsubstantiated by clinical data at this point but nonetheless rapidly growing in popularity
The statements below are direct attributions to peer-reviewed preclinical studies
Choi SM, Lee KM, Ryu SB, Park YJ, Hwang YG, Baek D, Choi Y, Park KH, Park KD, Lee JW
3 OASIS 4, 64-week study of adults with obesity using oral semaglutide 25mg alongside lifestyle changes